Quadrature Capital’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,870
Closed -$135K 1206
2024
Q2
$135K Buy
+17,870
New +$148K ﹤0.01% 1008
2020
Q1
Sell
-19,075
Closed -$530K 621
2019
Q4
$530K Sell
19,075
-13,661
-42% -$343K 0.02% 342
2019
Q3
$740K Buy
32,736
+2,874
+10% +$65.5K 0.04% 326
2019
Q2
$753K Buy
+29,862
New +$802K 0.05% 261
2018
Q3
Sell
-7,677
Closed -$332K 699
2018
Q2
$332K Buy
+7,677
New +$368K 0.03% 386
2017
Q4
Sell
-18,958
Closed -$817K 596
2017
Q3
$817K Buy
+18,958
New +$901K 0.1% 198
2016
Q1
Sell
-5,419
Closed -$388K 532
2015
Q4
$388K Buy
+5,419
New +$401K 0.06% 337

Other funds holding MD

Quadrature Capital's MD Position: Q3 2024 in Review

Quadrature Capital sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 17,870 shares — an estimated $135K sold.

Quadrature Capital first reported a position in MD in Q4 2015 and held it in 7 quarters. The position peaked at $817K in Q3 2017. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • Quadrature Capital reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
  • Quadrature Capital sold 17,870 Pediatrix Medical shares in Q3 2024, an estimated $135K.
  • Quadrature Capital first reported a position in Pediatrix Medical in Q4 2015 and held it in 7 quarters.
  • Quadrature Capital's Pediatrix Medical position peaked at $817K in Q3 2017.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Quadrature Capital's 13F filing for Q3 2024, filed 14 Nov 2024.